PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
Phosphatase of regenerating liver 3 (PRL3) is usually found intracellularly, and is over-expressed in cancer cells. Here the authors show that PRL-3 is also detectable on cell surface, and can be recognized by PRL3-zumab to recruit immune cells into tumor to promote anti-tumor immunity, thereby impl...
Main Authors: | Min Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta, Cheng Ean Chee, Soo Chin Lee, Kam Man Hui, Jie Li, Yeoh Khay Guan, Wei Peng Yong, Jimmy So, Wee Joo Chng, Chin Hin Ng, Jianbiao Zhou, Ling Zhi Wang, John Shyi Peng Yuen, Henry Sun Sien Ho, Sim Mei Yi, Edmund Chiong, Su Pin Choo, Joanne Ngeow, Matthew Chau Hsien Ng, Clarinda Chua, Eugene Shen Ann Yeo, Iain Bee Huat Tan, Joel Xuan En Sng, Nicholas Yan Zhi Tan, Jean Paul Thiery, Boon Cher Goh, Qi Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-10127-x |
Similar Items
-
PRL3 induces polypoid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
by: Min Thura, et al.
Published: (2021-07-01) -
Therapeutic potential of PRL-3 targeting and clinical significance of <it>PRL-3 </it>genomic amplification in gastric cancer
by: Nishimiya Hiroshi, et al.
Published: (2011-04-01) -
Ukradzione święto. Dożynki w PRL
by: Monika Milewska
Published: (2020-12-01) -
In search for the substrates of PRL-3, a protein encoded by PRL-3 gene implicated in colorectal cancer metastasis
by: Chiang Yu Wei, et al.
Published: (2004) -
Src-mediated phosphorylation of the tyrosine phosphatase PRL-3 is required for PRL-3 promotion of Rho activation, motility and invasion.
by: James J Fiordalisi, et al.
Published: (2013-01-01)